Skip to main content
Premium Trial:

Request an Annual Quote

Simulations Plus, FDA to Collaborate on Drug Development Study


Simulations Plus said this week that it has signed a five-year research collaboration agreement with the US Food and Drug Administration to work on determining the value of mechanistic absorption modeling (MAM) in developing predictive and robust in vitro/in vivo correlations.

Specifically, the collaborators will explore how MAM can be used to make more accurate predictions of complex drug absorption characteristics. The ultimate goal of the project, the company said in a statement, is to "facilitate drug and generic product development by decreasing the regulatory burden through adequate modeling approaches."

As part of the agreement, Simulations Plus will provide training and licenses for its GastroPlus simulation software to the FDA's Office of Testing and Research. The solution will be used to "model in vivo data [that is] representative of challenging absorption characteristics, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.